A
$ Value
$0
Shares
33,350
Price
$0
Filed
Jun 16
Insider
Name
BERMAN ANN E
Title
—
CIK
0001349408
Roles
Director
Transaction Details
Transaction Date
2025-06-13
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,350
Footnotes
The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first.
Filing Info
BERMAN ANN E's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | L | A | $0 |
| 2026-02-10 | L | ▼ | $212K |
| 2025-12-31 | L | A | $0 |
| 2025-12-01 | L | M | $87K |
| 2025-12-01 | L | D | $87K |
| 2025-12-01 | L | ▼ | $156K |
| 2025-12-01 | L | M | $0 |
| 2025-09-30 | L | A | $0 |
| 2025-09-02 | L | M | $80K |
| 2025-09-02 | L | D | $80K |
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
|
— | — | 2026-02-03 |
|
Zeskind Benjamin J.
PRESIDENT AND CEO
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-03-13 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |